Inadequate Reporting of Complications in Randomized Controlled Trials Cited as Supporting Evidence Underpinning AAOS CPG Recommendations for Hip and Knee Osteoarthritis: Application of the CONSORT Harms Checklist
- 13 June 2022
- journal article
- research article
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 37 (12) , 2466-2472.e2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic ReviewPLOS Medicine, 2016
- Update on the endorsement of CONSORT by high impact factor journals: a survey of journal “Instructions to Authors” in 2014Trials, 2016
- Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extensionBMJ Open, 2013
- Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewaSystematic Reviews, 2012
- Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysisBMJ, 2012
- The quality of safety reporting in trials is still suboptimal: Survey of major general medical journalsJournal of Clinical Epidemiology, 2011
- Brief Communication: Better Ways To Question Patients about Adverse Medical EventsAnnals of Internal Medicine, 2006
- Understanding randomised controlled trialsArchives of Disease in Childhood, 2005
- Balancing benefits and harms in health careBMJ, 2003
- Understanding adverse events: human factors.Quality and Safety in Health Care, 1995